Description:GSK1838705A, with the CAS number 1116235-97-2, is a chemical compound that has been investigated primarily for its potential therapeutic applications. It is classified as a small molecule and is known to act as a selective inhibitor of certain protein kinases, which play crucial roles in various cellular processes, including cell growth, differentiation, and metabolism. The compound has been studied in the context of various diseases, particularly cancer, due to its ability to modulate signaling pathways that are often dysregulated in tumorigenesis. GSK1838705A exhibits specific binding affinity to its target kinases, which contributes to its efficacy and selectivity. In terms of physical properties, detailed solubility, stability, and pharmacokinetic profiles are typically assessed during drug development, although specific values may vary based on formulation and testing conditions. Overall, GSK1838705A represents a promising candidate in the field of medicinal chemistry, particularly in the development of targeted therapies.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![2-[[2-[[1-[2-(Dimethylamino)acetyl]-2,3-dihydro-5-methoxy-1H-indol-6-yl]amino]-7H-pyrrolo[2,3-d]py…](https://static.cymitquimica.com/products/IN/thumb/DA003A9W.jpg)
![2-(2-(1-(2-(dimethylamino)acetyl)-5-methoxyindolin-6-ylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino…](https://static.cymitquimica.com/products/3D/thumb/FD43355.jpg)
